Claritev Corporation/$CTEV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Claritev Corporation
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Ticker
$CTEV
Sector
Primary listing
NYSE
Industry
Health Care Technology
Headquarters
Employees
2,700
ISIN
US62548M2098
Website
CTEV Metrics
BasicAdvanced
$687M
-
-$72.79
0.25
-
Price and volume
Market cap
$687M
Beta
0.25
52-week high
$43.83
52-week low
$4.80
Average daily volume
105K
Financial strength
Current ratio
1.024
Quick ratio
0.774
Long term debt to equity
31,141.484
Total debt to equity
31,271.649
Interest coverage (TTM)
0.23%
Profitability
EBITDA (TTM)
511.69
Gross margin (TTM)
74.15%
Net profit margin (TTM)
-126.96%
Operating margin (TTM)
8.20%
Effective tax rate (TTM)
9.35%
Revenue per employee (TTM)
$340,000
Management effectiveness
Return on assets (TTM)
0.83%
Return on equity (TTM)
-198.69%
Valuation
Price to revenue (TTM)
0.729
Price to book
46.33
Price to tangible book (TTM)
-0.15
Price to free cash flow (TTM)
-6.856
Free cash flow yield (TTM)
-14.59%
Free cash flow per share (TTM)
-609.54%
Growth
Revenue change (TTM)
-3.33%
Earnings per share change (TTM)
91.69%
3-year revenue growth (CAGR)
-7.21%
3-year earnings per share growth (CAGR)
127.34%
Bulls say / Bears say
Claritev's rebranding and strategic vision aim to position the company as a market-leading health technology organization, potentially enhancing its market presence and investor confidence. (Claritev Reports Fourth Quarter and Full Year 2024 Results)
The company's international expansion through a partnership with Burjeel Holdings to enter the Middle East and North Africa region opens up a healthcare claims market worth approximately $21 billion, indicating significant growth potential. (Claritev Q1 2025 slides: Revenue dips 1.4%, Payment Integrity segment shines)
Claritev's Payment and Revenue Integrity segment experienced a 9.7% year-over-year growth in Q1 2025, showcasing the company's ability to capitalize on specific growth areas despite broader revenue challenges. (Earnings call transcript: Claritev Corp Q1 2025 sees revenue dip, stock reacts negatively)
Claritev reported a net loss of $1.65 billion in 2024, a significant increase from the $91.7 million net loss in 2023, primarily due to a $1.49 billion impairment of goodwill and intangible assets. (Form 10-K for the fiscal year ended December 31, 2024)
The company's revenue declined by 3.2% in 2024 compared to the prior year, driven by a 17.1% decrease in Network-Based Services revenues, indicating challenges in maintaining revenue growth. (Form 10-K for the fiscal year ended December 31, 2024)
Claritev's stock experienced a 28% decline in March 2025, reflecting investor concerns over the company's financial performance and future prospects. (Little Excitement Around Claritev Corporation's (NYSE:CTEV) Revenues As Shares Take 28% Pounding)
Data summarised monthly by Lightyear AI. Last updated on 5 Jun 2025.
CTEV News
AllArticlesVideos
Fractional AI Announces Strategic Collaboration to Accelerate Claritev's Generative AI Strategy
Business Wire·1 day ago
Great Speech's Virtual Speech Therapy Services Now Available to Health Plan Members accessing Claritev's National PPO Networks
GlobeNewsWire·2 months ago
Claritev and Burjeel Holdings Partner to Advance Revenue Integrity Solutions in the MENA Region
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Claritev Corporation stock?
Claritev Corporation (CTEV) has a market cap of $687M as of June 26, 2025.
What is the P/E ratio for Claritev Corporation stock?
The price to earnings (P/E) ratio for Claritev Corporation (CTEV) stock is 0 as of June 26, 2025.
Does Claritev Corporation stock pay dividends?
No, Claritev Corporation (CTEV) stock does not pay dividends to its shareholders as of June 26, 2025.
When is the next Claritev Corporation dividend payment date?
Claritev Corporation (CTEV) stock does not pay dividends to its shareholders.
What is the beta indicator for Claritev Corporation?
Claritev Corporation (CTEV) has a beta rating of 0.25. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.